Acumen Hypotension Prediction Index (HPI) Feature Software vs ASSURE Wearable ECG

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Kestra Medical Technologies

AI Verdict

Tool A is designed for proactive prediction of hypotensive events in acute care settings, leveraging machine learning on blood pressure data to guide immediate hemodynamic management. Tool B, conversely, focuses on continuous, long-term heart rate monitoring via a wearable device, primarily for remote patient management and detection of cardiac irregularities in at-risk outpatients. While both utilize AI in cardiology, their distinct applications in acute vs. remote care and their specific physiological targets make them adjacent rather than direct competitors.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if your primary need is real-time, predictive monitoring to proactively prevent and manage hypotensive events in critically ill or surgical patients. This tool is ideal for settings where early detection of hemodynamic instability, up to 15 minutes before it occurs, is crucial for improving patient outcomes through timely intervention.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if you require continuous, long-term heart rate monitoring and data collection for at-risk cardiac patients in an outpatient or remote setting. This wearable device is best suited for identifying cardiac trends, automatically storing episodes, and providing alert-based notifications to clinicians for ongoing patient management outside of acute care.

View ASSURE Wearable ECG →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index (HPI) Feature Software ASSURE Wearable ECG
Pricing Unknown Contact for pricing.
Deployment Unknown Wearable device, mobile application, and cloud-based remote patient data platform.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ASSURE Wearable ECG

Tool B, the ASSURE Wearable ECG, focuses on patient usability with its comfortable SensorFit Garment and mobile application, making continuous monitoring accessible for at-risk cardiac patients. While Tool A integrates into existing critical care workflows for clinicians, Tool B's design prioritizes ease of use for the patient in a remote monitoring context.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A, Acumen HPI, offers a strong and specific clinical value proposition by demonstrating a reduction in the incidence, duration, and severity of intraoperative hypotension. This direct impact on patient outcomes through proactive hemodynamic management is explicitly stated. Tool B provides valuable continuous monitoring data, but the provided information does not quantify its direct impact on clinical outcomes in the same way.

Pricing & Value

Tie

Both Tool A and Tool B state that pricing information is not publicly available and requires contacting the vendor. Without transparent pricing details for either product, it is impossible to conduct a meaningful comparison of their relative pricing and value.

Enterprise Readiness

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A is integrated into Edwards Lifesciences' HemoSphere advanced monitoring platform, a widely adopted system in acute care settings, indicating strong readiness for deployment within existing hospital infrastructure. Both tools are FDA cleared, HIPAA compliant, and have BAAs, but Tool A benefits from being part of a larger, established enterprise ecosystem with extensive hospital presence.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A is described as a 'first-of-its-kind technology' that uses machine learning to predict hypotensive events up to 15 minutes before they occur, representing a significant advancement in proactive critical care. While Tool B features innovative elements for a wearable ECG, the predictive analytics of Tool A for a critical, time-sensitive physiological event stands out as more groundbreaking.

Support & Docs

Acumen Hypotension Prediction Index (HPI) Feature Software

Edwards Lifesciences, the company behind Acumen HPI, is a large and established medical device manufacturer known for its comprehensive clinical education, technical support, and extensive documentation for its products. While Kestra Medical Technologies also provides support for its wearable, the breadth and depth of support from a major enterprise like Edwards are generally more robust and readily available for clinicians.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index (HPI) Feature Software ASSURE Wearable ECG
Name Acumen Hypotension Prediction Index (HPI) Feature Software ASSURE Wearable ECG
Company Edwards Lifesciences Kestra Medical Technologies
Description Edwards Lifesciences' Acumen Hypotension Prediction Index (HPI) software is a predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management and improving patient outcomes. Kestra Medical Technologies offers the ASSURE Wearable ECG, a non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients.
Categories Cardiology AI, Triage & ER/ICU AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology
Key Features (Example 1) Hypotension Prediction Index (HPI) parameter (0-100 score) Wearable ECG device for continuous heart rate monitoring
Key Features (Example 2) Predicts hypotension up to 15 minutes before an event SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors
Key Features (Example 3) Compatibility with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring Kestra CareStation remote patient data platform for clinician review

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and ASSURE Wearable ECG.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI software is a predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management. The ASSURE Wearable ECG is a non-therapeutic device for continuous heart rate monitoring and data collection, primarily for at-risk cardiac patients.
Acumen HPI software utilizes machine learning algorithms to analyze blood pressure waveforms and provides a Hypotension Prediction Index (HPI) parameter (0-100 score) to predict hypotension. It also offers insights into preload, afterload, and contractility. The ASSURE Wearable ECG monitors continuous heart rate through its wearable ECG device and embedded sensors.
Acumen HPI software is integrated into Edwards Lifesciences' HemoSphere advanced monitoring platform, typically used in acute care settings like the ER or ICU. The ASSURE Wearable ECG system includes a wearable device, a mobile application, and a cloud-based remote patient data platform (Kestra CareStation) for clinician review, suitable for both home and clinical settings.
Acumen HPI software is explicitly predictive, designed to predict hypotension up to 15 minutes before an event occurs. The ASSURE Wearable ECG focuses on continuous monitoring, automatic episode storage, and alert-based notifications for heart rate, rather than predicting future events.
Acumen HPI software is compatible with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring. The ASSURE Wearable ECG is a non-invasive wearable device featuring a SensorFit Garment with non-adhesive, embedded ECG sensors and Adaptive Patient Intelligence for filtering motion artifacts.
Acumen HPI software has demonstrated a reduction in the incidence, duration, and severity of intraoperative hypotension. The ASSURE Wearable ECG provides continuous heart rate monitoring with automatic episode storage and alert-based notifications for clinician review, and studies on the related ASSURE Wearable Cardioverter Defibrillator (WCD) system have shown high patient compliance and effective detection of ventricular arrhythmias.

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.